📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees (2022)

First Author: Rungtiwa Nutalai

Attributed to: Structural Studies on Viruses, Viral Proteins and Cell Interactions funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.60692/hr2yy-1vh62

Publication URI: https://gresis.osc.int//doi/10.60692/hr2yy-1vh62

Type: Other